Recent Market Intelligence Report on Magnesium Stearate

I. Price Dynamics
- **Shandong Qiangsen Chemical Co., Ltd. Quotation**: From April 14 to April 18, 2026, the tax-inclusive ex-factory price for premium-grade magnesium stearate remained stable at RMB 9,800 per metric ton.
- **Overall Market Price Trend**: Recently, magnesium stearate prices have shown no significant fluctuations; however, close attention should be paid to changes in the price of its raw material—stearic acid. As of May 22, 2026, the transaction price for domestic Grade I stearic acid in the East China region stood at RMB 10,000–10,200 per metric ton, down 4% month-on-month; the transaction price for mainstream imported stearic acid was RMB 10,100–10,300 per metric ton, also down 4% month-on-month.

II. Supply-Demand Situation
- **Supply Side**:
- Production capacity utilization at magnesium stearate manufacturers remains stable, and inventory levels are maintained at medium-to-low levels.
- The supply of stearic acid provides certain support to the market; however, fluctuations in palm oil prices—which impact stearic acid production—warrant monitoring.
- **Demand Side**:
- As a pharmaceutical excipient, magnesium stearate demand is significantly influenced by the pharmaceutical industry. With ongoing expansion of the pharmaceutical industry and enhanced standardization of pharmaceutical excipients, demand for magnesium stearate continues to grow steadily.
- Tablet manufacturing accounts for over 65% of total consumption, while capsule manufacturing represents approximately 20%. Long-term medication requirements for chronic diseases—including cardiovascular and diabetes treatments—continue to unlock incremental market potential.

III. Key Market Drivers
- **Regulatory Policies**: The National Medical Products Administration’s (NMPA) implementation of the linked review and approval system, along with the enforcement of the *Chinese Pharmacopoeia* (2020 Edition), has raised industry entry barriers and quality standards—prompting enterprises to strengthen technological innovation and quality control.
- **Pharmaceutical Industrial Restructuring**: Ongoing restructuring within the pharmaceutical industry strongly drives demand for magnesium stearate. Demand for high-purity, low-heavy-metal magnesium stearate products is growing at an annual average rate exceeding 12%.
- **Raw Material Price Volatility**: Fluctuations in stearic acid prices directly affect magnesium stearate production costs—and consequently influence its market pricing.

IV. Competitive Landscape
- **Rising Industry Concentration**: The combined market share of the top 10 enterprises increased from 42.6% in 2021 to 51.3%, reflecting a continuous consolidation trend across the sector.
- **Advantages of Leading Enterprises**: Industry leaders—including Hunan Erkang Pharmaceutical Co., Ltd. and Anhui Shanhe Pharmaceutical Excipients Co., Ltd.—maintain dominant positions, leveraging advantages in GMP certification, R&D capabilities, and established customer channels.

Analysis & Assessment

I. Price Trend Outlook
- Magnesium stearate prices have remained stable recently; however, future price movements remain uncertain due to volatility in stearic acid prices. Sustained declines in raw material prices could exert downward pressure on magnesium stearate pricing, whereas rebounds in stearic acid prices may trigger corresponding upward adjustments.

II. Supply-Demand Outlook
- On the supply side, stable production capacity utilization and moderate inventory levels ensure sufficient supply capability.
- On the demand side, continued pharmaceutical industry expansion and improved excipient standardization support steady demand growth. Nevertheless, shifts in procurement strategies among downstream pharmaceutical manufacturers—as well as emerging opportunities in new pharmaceutical markets—require close observation.

III. Competitive Outlook
- Industry concentration is expected to further increase, with leading enterprises expanding their market shares. Small- and medium-sized enterprises face mounting competitive pressures and must enhance technological innovation and quality control to bolster competitiveness—while also exploring differentiated strategies to achieve market breakthroughs.

Forecast

I. Price Forecast
- Magnesium stearate prices are expected to remain relatively stable in the near term; however, timely monitoring of stearic acid price fluctuations is essential. Significant volatility in raw material pricing may prompt corresponding adjustments in magnesium stearate market prices.

II. Supply-Demand Forecast
- On the supply side, stable production capacity utilization and progressive inventory digestion will sustain adequate supply capacity.
- On the demand side, continued pharmaceutical industry growth and higher excipient standardization will underpin steady demand expansion. However, evolving procurement behaviors among downstream pharmaceutical manufacturers—and the development potential of emerging pharmaceutical markets—deserve continued attention.

III. Competitive Forecast
- Industry concentration is projected to continue rising, with leading enterprises further extending their market dominance. SMEs must intensify efforts in technological innovation and quality management to enhance competitiveness, while simultaneously pursuing differentiated strategies to secure competitive advantage.